BTAI Stock Analysis: Buy, Sell, or Hold?
BTAI - BioXcel Therapeutics, Inc. Common Stock
$0.90
-0.29 (-24.60%)
âŧ
5d:
-3.3%
30d:
+1.12%
90d:
-21.29%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When BTAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BTAI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BTAI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: BTAI is currently trading at $0.90, which is considered fair relative to its 30-day fair value range of $0.81 to $0.99.
Technical Outlook: Technically, BTAI is in a strong uptrend. Immediate support is located at $0.80, while resistance sits at $1.24. Short-term momentum is weak, with the stock down 24.6% recently.
Market Sentiment: BTAI scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.00 (+1076.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BTAI is in a strong uptrend. Immediate support is located at $0.80, while resistance sits at $1.24. Short-term momentum is weak, with the stock down 24.6% recently.
Market Sentiment: BTAI scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.00 (+1076.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.81 -
$0.99
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-24.6%)
- BULLISH: Trading 1076.5% below Wall St target ($14.00)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.81 -
$0.99
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.80
Resistance Level
$1.24
Current Trend
Strong Uptrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.77
Wall Street Target
$14.00
(+1076.5%)
Revenue Growth (YoY)
22.6%
Share & Embed Analysis
Last updated: August 17, 2026 12:11 PM ET
Data refreshes hourly during market hours. Next update: 1:11 PM
Data refreshes hourly during market hours. Next update: 1:11 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
25 analysts |
$212 | 61 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 56 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$101 | 44 HOLD |
|
INDV
Indivior PLC Ordinary ShâĻ |
STRONG BUY
7 analysts |
$49 | 69 BUY |
|
ALKS
Alkermes Plc |
BUY
15 analysts |
$56 | 68 BUY |
